Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
暂无分享,去创建一个
J. Olalla | M. Mayorga | C. González-Domenech | A. Romero | R. Palacios | J. Hernández-Quero | J. Santos | J. M. Romero | I. Pérez-Camacho | M. Omar | I. Pérez-Hernández | M. Martínez